Update on the prevention and treatment of sexually transmitted diseases

American Family Physician

Volumn 61, Issue 2, 2000, Pages 379-386

  Miller, Karl E ^a   Graves, J Christopher ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTETAN; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; HEPATITIS A VACCINE; IMIQUIMOD; METRONIDAZOLE; OFLOXACIN; PODOPHYLLOTOXIN; QUINOLONE DERIVATIVE; SULBACTAM; SULTAMICILLIN;

ANTIBIOTIC THERAPY; ANTIVIRAL ACTIVITY; CONGENITAL SYPHILIS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE TRANSMISSION; GENITAL HERPES; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; OUTPATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TREATMENT PLANNING;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FAMILY PRACTICE; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 0034650848     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Summary of notifiable diseases, United States, 1997. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;46:3-87.
2. 1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1993;42(RR-14):1-102.
3. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-1):1-111.
4. Main J, McCarron B, Thomas HC. Treatment of chronic viral hepatitis. Antivir Chem Chemother 1998;9:449-60.
5. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996;45(RR-15):1-30 [published erratum appears in MMWR Morb Mortal Wkly Rep 1997;46:588].
6. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996;45(RR-15):1-30 [published erratum appears in MMWR Morb Mortal Wkly Rep 1997;46:588].
7. Newkirk GR. Pelvic inflammatory disease: a contemporary approach. Am Fam Physician 1996;53: 1127-35.
8. Webb DH, Fife KH. Genital herpes simplex virus infections. Infect Dis Clin North Am 1987;1:97-122.
9. Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S, et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 1997;73:105-9.
10. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998;280:887-92.
11. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones - Ohio and Hawaii, 1992-1994. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1994;43:325-7.
12. Mayeaux EJ Jr, Harper MB, Barksdale W, Pope JB. Noncervical human papillomavirus genital infections. Am Fam Physician 1995;52:1137-50.
13. Gabel LL, Pearsol JA. Taking an effective sexual and drug history. A first step in HIV/AIDS prevention. J Fam Pract 1993;37:185-7.